Vital Signs - Personalized Biomarkers: From Drug Discovery to Diagnostics, Therapeutics, and Monitoring

Vital Signs - Personalized Biomarkers: From Drug Discovery to Diagnostics, Therapeutics, and Monitoring

 

RELEASE DATE
07-Jul-2008
REGION
North America
Research Code: 9561-00-68-00-00
SKU: HC00535-NA-MR_04007
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00535-NA-MR_04007

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on July 7, 2008, provides an strategic overview of the use of personalized biomarkers in healthcare. Additionally, a company spotlight is provided for febit Inc., a leader in instrumentation for automated DNA microarray synthesis and analysis. Reimbursement and regulatory news from the FDA is also provided for the week of June 21, 2008.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on July 7, 2008, provides an strategic overview of the use of personalized biomarkers in healthcare. Additionally, a company spotlight is provided for febit Inc., a leader in instrumentation for automated DNA microarray synthesis and analysis. Reimbursement and regulatory news from the FDA is also provided for the week of June 21, 2008.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-68-00-00
Is Prebook No